Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Acute and Post-acute Sequelae of SARS-CoV-2 Infection: Focus on Systemic Complications"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 June 2023 | Viewed by 5134
Special Issue Editor
Interests: acute coronary syndrome; interventional cardiology; biomarkers
Special Issue Information
The coronavirus disease (COVID-19) due to a novel coronavirus (CoV2) has rapidly spread worldwide and changed various systems, especially healthcare systems. This virus not only affects the pulmonary parenchyma but also profoundly impacts the cardiovascular system. Systemic complications associated with SARS-CoV2 infection are frequently found in COVID-19 disease, with several manifestations and indiscriminate havoc on multiple organ systems including the heart, brain, kidney, and the vasculature. Moreover, long COVID-19 syndrome has emerged as a new pandemic, causing substantial disability to millions of people globally.
Therefore, we would like to encourage the presentation to this Special Issue additional insights on the link between COVID-19 disease and systemic complications, in order to provide clinicians a range of the potential manifestations of SARS-CoV-2 beyond the destructive lung infection.
Adding new information on these subjects may lead to a better understanding of the pathogenesis not only of COVID-19 infection but also of different diseases and aid in the design of new therapeutic and prophylactic strategies.
Dr. Andrea Denegri
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiovascular and systemic complications
- post-acute sequelae of SARS-CoV-2 infection
- long COVID-19 syndrome